Clinical Trials Update: Oct. 19, 2009

• High Cholesterol
• Hepatitis C
• Metastatic Colorectal Cancer - PEAK Study

(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:

High Cholesterol

This study will evaluate the effectiveness of a new medication is in lowering lipid levels. The medication is niacin based with non-flushing properties.

The research site is in Lincoln, Calif.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/high_cholesterol.aspx.

-----

Hepatitis C

This study is evaluating an investigational drug to treat hepatitis C. The trial will evaluate how the drug is absorbed, changed and removed from the body.

The research site is in Baltimore, Md.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/hepatitis.aspx.

-----

Metastatic Colorectal Cancer - PEAK Study

This study is for people with colorectal cancer that has metastasized (spread). The study will evaluate an investigational human monoclonal antibody combined with chemotherapy to see if it extends survival, compared to the best available standard of care.

The research site is in Huntsville, Ala.

More information

Please see http://www.clinicalconnection.com/clinical_trials/condition/colorectal_cancer.aspx.

-----

Copyright 2009 ClinicalConnection.com. All rights reserved.